AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6217921
Drug: aspirin/dipyridamole
RxNorm normalized name: ASPIRIN/DIPYRIDAMOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin/dipyridamole
Trial: 30694697
Drug: Dasotraline 2
RxNorm normalized name: Dasotraline
DrugBank: Dasotraline (DB12305)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasotraline 2 mg/day
Trial: 30007039
Drug: PRF +
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PRF + 1% Alendronate (ALN) gel
Trial: 7916914
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 30 mg
Trial: 937355
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate 15 mg
Trial: 2811648
Drug: Single drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drug for movement disorder
Trial: 2811648
Drug: Potentially useful
RxNorm normalized name: Potentilla discolor whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potentially useful but toxic drug
Trial: 20974604
Drug: GW274150 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GW274150 60 mg
Trial: 22409880
Drug: Prednisolone 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 7.5 mg
Trial: 20858230
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of training and RDTs (AB)
Trial: 19039291
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (bi-weekly telephone call, no exercise intervention)
Trial: 14666757
Drug: TCM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCM treatment based on syndrome differentiation of TCM
Trial: 14666757
Drug: Conventional method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional method of western medicine (Control)
Trial: 11011339
Drug: Unfractionated Heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated Heparin (UFH) - Subtherapeutic
Trial: 11011339
Drug: Unfractionated Heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated Heparin (UFH) - Therapeutic
Trial: 11011339
Drug: Unfractionated Heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated Heparin (UFH) - Supratherapeutic
Trial: 1818759
Drug: Salmon calcitonin
RxNorm normalized name: Salmon calcitonin
DrugBank: Salmon calcitonin (DB00017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon calcitonin (100 IU) daily injections
Trial: 11897434
Drug: Low serum
RxNorm normalized name: ZINC OXIDE 20 g in 100 mL TOPICAL CREAM [Sunceutical SPF 50 Mineral Glow Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low serum digoxin concentration (0.5 to 0.9 ng/ml)
Trial: 11897434
Drug: Moderate serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate serum digoxin concentration (0.9 to 1.2 ng/ml)
Trial: 11897434
Drug: High serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High serum digoxin concentration (>1.2 ng/ml)
Trial: 2271507
Drug: Adenine arabinoside
RxNorm normalized name: Adenine
DrugBank: Adenine (DB00173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenine arabinoside (Ara‐A) 15 mg/Kg, iv, for 10 days
Trial: 31390002
Drug: Nicotinamide riboside
RxNorm normalized name: Nicotinamide riboside
DrugBank: Nicotinamide riboside (DB14933)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide riboside (NR) at 1000 mg twice daily
Trial: 16769988
Drug: EC +
RxNorm normalized name: EC-0652
DrugBank: EC-0652 (DB15340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EC + G‐CSF
Trial: 16769988
Drug: Schedule 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule 5 G‐CSF
Trial: 16769988
Drug: Seven or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seven or four G‐CSF injections
Trial: 11672897
Drug: RIVM hexavalent
RxNorm normalized name: botulinum neurotoxin B immune FAB2
DrugBank: Equine Botulinum Neurotoxin B Immune FAB2 (DB13903)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIVM hexavalent OMV vaccine (three doses at 0, 2, and 8 months)
Trial: 11672897
Drug: RIVM hexavalent
RxNorm normalized name: botulinum neurotoxin B immune FAB2
DrugBank: Equine Botulinum Neurotoxin B Immune FAB2 (DB13903)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIVM hexavalent OMV vaccine
Trial: 12420901
Drug: Problem-solving treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-solving treatment
Trial: 9153693
Drug: Drug placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug placebo with standard clinical management
Trial: 2974302
Drug: PTFE (Gore‐Tex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTFE (Gore‐Tex CV patch)
Trial: 21258804
Drug: Mud pack
RxNorm normalized name: Cream, Multi Ingredient Topical application Cream [3 ROSES FACIAL MUD PACK]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mud pack therapy
Trial: 21258804
Drug: Hot pack
RxNorm normalized name: cold-hot pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hot pack therapy
Trial: 20102667
Drug: Propranolol (β-noradrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (β-noradrenergic antagonist)
Trial: 16377919
Drug: Nifekalant (NIF)
RxNorm normalized name: Nifekalant
DrugBank: Nifekalant (DB16008)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifekalant (NIF) 0.15-0.3 mg/kg
Trial: 12822874
Drug: Interferon-alpha2b +
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha2b + Ribavirin (1000-1200 mg/day for 48 weeks)
Trial: 11402829
Drug: Viscoelastics (ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viscoelastics (ophthalmic viscosurgical device, OVD)
Trial: 8428323
Drug: estramustine phosphate
RxNorm normalized name: Estramustine phosphate
DrugBank: Estramustine phosphate (DB14674)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: estramustine phosphate 600 mg/m2 orally daily for up to 2 years
Trial: 8428323
Drug: adjuvant cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: adjuvant cyclophosphamide 1 g/m2 intravenously every 3 weeks for 2 years
Trial: 8428323
Drug: no adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no adjuvant therapy
Trial: 2892864
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg at 10 PM
Trial: 28003041
Drug: Oat consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oat consumption group (50 g/day oats)
Trial: 25647729
Drug: Tenofovir 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir 1% gel
Trial: 24012319
Drug: Rifaximin 200
RxNorm normalized name: rifAXIMin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin 200 mg tablets twice daily
Trial: 19061374
Drug: L-Dopa (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Dopa (200 mg)
Trial: 17333809
Drug: Doxycycline, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline, 2 x 200 mg/day for 1 week
Trial: 17333809
Drug: Praziquantel, single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel, single dose, 40 mg/kg body weight
Trial: 17333809
Drug: Oxytetracycline, 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytetracycline, 15 mg in 0.5 mL medium (in vitro)
Trial: 17333809
Drug: Extract of
RxNorm normalized name: Extract of tomato
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extract of Eucalyptus comaldensis, 50 mg in 0.1 mL medium (in vitro)
Trial: 10724022
Drug: pivmecillinam, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivmecillinam, 200 mg three times daily for 3 days
Trial: 10724022
Drug: cephalexin, 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cephalexin, 250 mg four times daily for 7 days
Trial: 8730167
Drug: Protective Creams
RxNorm normalized name: ostomy, skin fillers, protective creams & sprays
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective Creams (PCs) against 10% sodium lauryl sulfate (SLS)
Trial: 8730167
Drug: Protective Creams
RxNorm normalized name: ostomy, skin fillers, protective creams & sprays
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective Creams (PCs) against undiluted toluene (TOL)
Trial: 8730167
Drug: Protective Creams
RxNorm normalized name: ostomy, skin fillers, protective creams & sprays
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective Creams (PCs) against 1% sodium hydroxide (NaOH) and 30% lactic acid (LA)
Trial: 8730167
Drug: Protective Creams
RxNorm normalized name: ostomy, skin fillers, protective creams & sprays
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective Creams (PCs) against SLS and NaOH
Trial: 26596013
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone injection as initial treatment (group A)
Trial: 26596013
Drug: Systemic hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic hormone therapy (group B)
Trial: 26596013
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone injection as salvage treatment (group C)
Trial: 20617919
Drug: Paraffin baths
RxNorm normalized name: Paraffin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paraffin baths 80% wax with 20% topical analgesic (PTA)
Trial: 10336539
Drug: Morphine (MOR)
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine (MOR) 2.5, 5, and 10 mg/70 kg
Trial: 10336539
Drug: Hydromorphone (HM)
DrugBank: Hydromorphone (DB00327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydromorphone (HM) 0.33, 0.65, and 1.3 mg/70 kg
Trial: 10336539
Drug: Meperidine (MEP)
DrugBank: Meperidine (DB00454)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine (MEP) 17.5, 35, and 70 mg/70 kg
Trial: 30058511
Drug: Discontinued antipsychotic
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinued antipsychotic treatment
Trial: 30058511
Drug: Continued antipsychotic
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued antipsychotic treatment
Trial: 27531506
Drug: Intensified, multifactorial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified, multifactorial treatment (mean treatment duration 7.8 years)
Trial: 27531506
Drug: Intensified, multifactorial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified, multifactorial treatment
Trial: 24418924
Drug: 2D video
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2D video preparation
Trial: 24418924
Drug: 3D video
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3D video preparation
Trial: 24418924
Drug: Guide preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guide preparation
Trial: 15535489
Drug: lignocaine 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lignocaine 2% (40 mg)
Trial: 11674912
Drug: 50% dextrose
RxNorm normalized name: DEXTROSE MONOHYDRATE 5000 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Alfa Veterinary 50% Dextrose]
DrugBank: D-glucose (DB01914)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% dextrose solution
Trial: 17077809
Drug: Risperidone 1
RxNorm normalized name: risperidone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 1 mg/day
Trial: 17077809
Drug: Risperidone 4
RxNorm normalized name: risperidone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 4 mg/day
Trial: 7521534
Drug: Risperidone 8
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone 8 mg/day
Trial: 9477007
Drug: Risperidone 12
RxNorm normalized name: risperidone 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 12 mg/day
Trial: 7521534
Drug: Haloperidol 10
RxNorm normalized name: haloperidol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 10 mg/day
Trial: 9477007
Drug: Risperidone (>=
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (>= 4 mg/day)
Trial: 9477007
Drug: Risperidone 1
RxNorm normalized name: risperidone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone 1 or 4 mg/day
Trial: 9477007
Drug: Risperidone (optimal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (optimal dose)
Trial: 3363287
Drug: Pirenzepine 100
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 100 mg/day for 3 days
Trial: 30419120
Drug: Amoxicillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (3 days, twice daily)
Trial: 30419120
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 days, twice daily)
Trial: 27848159
Drug: Recent chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Recent chemotherapy (Group R)
Trial: 27848159
Drug: No recent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No recent chemotherapy (Group O)
Trial: 23760292
Drug: Low-sodium/high-potassium diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium/high-potassium diet with furosemide infusion
Trial: 18164013
Drug: B1B1/CC genotype
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B1B1/CC genotype
Trial: 17062300
Drug: Paracetamol tablet
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol tablet containing sodium bicarbonate (PSC)
Trial: 12702521
Drug: Epirubicin-Cyclophosphamide at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin-Cyclophosphamide at intermediate doses (EC)
Trial: 12702521
Drug: Epirubicin-Cyclophosphamide at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin-Cyclophosphamide at full doses (HEC)
Trial: 1687238
Drug: Mequitazine (MQZ)
RxNorm normalized name: mequitazine
DrugBank: Mequitazine (DB01071)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mequitazine (MQZ) 5 mg BID for 7 days
Trial: 6364621
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg phenylethylamine in apple juice
Trial: 6364621
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg histamine in apple juice
Trial: 6364621
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg tyramine in apple juice
Trial: 31748594
Drug: Fenofibrate (145
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (145 mg tablet) administered once daily for 2 months (Mo2)
Trial: 31748594
Drug: Fenofibrate (145
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (145 mg tablet) administered once daily for 4 months (Mo4)
Trial: 27913736
Drug: Topical tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical tranexamic acid (1g in 100mL normal saline during sternal closure)
Trial: 25958710
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl at 1 mcg/kg/dose
Trial: 25958710
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine at 1 mg/kg/dose
Trial: 19635277
Drug: Tinzaparin 175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinzaparin 175 IU/kg subcutaneously once daily for 12 weeks
Trial: 19635277
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (tinzaparin for >or=5 days plus oral warfarin for >or=12 weeks)
Trial: 16631323
Drug: ondansetron 4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 4.0 mg
Trial: 16631323
Drug: ondansetron 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 1.0 mg
Trial: 9778323
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy (aspirin and ticlopidine)
Trial: 9778323
Drug: Conventional anticoagulation
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anticoagulation (heparin or oral anticoagulant)
Trial: 7527131
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose aprotinin
Trial: 27159397
Drug: 15 mcg
RxNorm normalized name: DDAVP 15 MCG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mcg vaccine
Trial: 27159397
Drug: 30 mcg
RxNorm normalized name: Avonex 30 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mcg vaccine
Trial: 27159397
Drug: Both 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both 15 mcg and 30 mcg vaccines
Trial: 21551462
Drug: Dabigatran 50
RxNorm normalized name: dabigatran 50 mg oral granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 50 mg
Trial: 11104182
Drug: Cognitive preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive preparation prior to video feedback
Trial: 11104182
Drug: No cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No cognitive preparation (Control)
Trial: 1364968
Drug: Olimunostim (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olimunostim (7 consecutive daily doses, perorally)
Trial: 7372036
Drug: Treatment groups
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment groups (individual-oriented intervention for high-risk subjects and mass health education for the remaining 70%)
Trial: 7372036
Drug: Treatment groups
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment groups (high-risk subgroups)
Trial: 7372036
Drug: Treatment groups
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment groups (random population)
Trial: 7372036
Drug: Treatment groups
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment groups (whole treatment populations)
Trial: 22907790
Drug: 240 ml
RxNorm normalized name: Iron 5 MG/240 ML Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 ml daily of 100% Concord grape juice
Trial: 19893995
Drug: Diphtheria-tetanus-pertussis/Hib Brazilian
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
Trial: 17300239
Drug: Simplified creams
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simplified creams
Trial: 17300239
Drug: Lipid-free gel
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-free gel
Trial: 17300239
Drug: Ordinary cream
RxNorm normalized name: ordinary salt combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary cream (5% urea)
Trial: 17300239
Drug: One of
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One of the simplified creams
Trial: 17300239
Drug: All test
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All test preparations
Trial: 16624688
Drug: Caffeine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (4 mg/kg intravenously, equivalent to 2 cups of coffee)
Trial: 12515871
Drug: ACE-inhibitor infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACE-inhibitor infusion during CPT
Trial: 12515871
Drug: ACE-inhibitor infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACE-inhibitor infusion after dipyridamole
Trial: 1692687
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg propranolol (beta-blocker)
Trial: 7025784
Drug: Imipramine hydrochloride;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine hydrochloride; treatment duration: three-week treatment periods.
Trial: 7025784
Drug: Placebo; treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo; treatment duration: three-week treatment periods.
Trial: 29354990
Drug: Alliance therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alliance therapy group with scalp acupuncture, music therapy and rehabilitation
Trial: 29354990
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group with music therapy and rehabilitation
Trial: 25430812
Drug: Pregabalin 75
RxNorm normalized name: pregabalin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 75 mg orally twice daily for 2 weeks starting on the day of surgery
Trial: 25430812
Drug: Loxoprofen orally
RxNorm normalized name: loxoprofen
DrugBank: Loxoprofen (DB09212)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Loxoprofen orally three times daily for 2 weeks starting on the day of surgery